You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pseudomonas aeruginosa

Showing 1 - 25 of 592
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pseudomonas Aeruginosa Infections Among COVID-19 Intensive Care

Not yet recruiting
  • Pseudomonas Aeruginosa
  • COVID-19
  • Observation
  • Vandœuvre-lès-Nancy, Lorraine, France
    Nancy University Hospital
Nov 17, 2023

Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

Recruiting
  • Bladder Cancer
  • Pseudomonas aeruginosa
  • Jinan, Shandong, China
    Qilu hospital
Jul 26, 2023

Efflux Pump and Virulence Factors Genes in Pseudomonas

Not yet recruiting
  • Pseudomonas Aeruginosa
  • culture on cetrimide agar
  • +3 more
  • (no location specified)
Nov 29, 2022

During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia

Completed
  • Pseudomonas Aeruginosa
  • Ventilation Acquired Pneumonia
    • Grenoble, Isère, France
      Medical ICU of Universitary Hospital of Grenoble
    Nov 7, 2022

    Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection Trial in Farmington, Tyler (AP-PA02, Placebo)

    Recruiting
    • Non-cystic Fibrosis Bronchiectasis
    • +2 more
    • AP-PA02
    • Placebo
    • Farmington, Connecticut
    • +1 more
    Jan 13, 2023

    Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

    Completed
    • Pseudomonas Infection
    • Cystic Fibrosis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jun 3, 2022

      Isolation of Human Recombinant Therapeutic Monoclonal

      Recruiting
      • Pseudomonas Aeruginosa
      • Multi-antibiotic Resistance
      • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
      • Grenoble, France
        Chu Grenoble Alpes
      May 6, 2022

      Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection Trial (Rapid Diagnostics)

      Not yet recruiting
      • Blood Stream Infections
      • +4 more
      • Rapid Diagnostics
      • (no location specified)
      Jul 31, 2023

      Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

      Recruiting
      • Pseudomonas Aeruginosa
      • +2 more
        • Jakarta, Indonesia
        • +2 more
        Mar 22, 2022

        Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa

        Active, not recruiting
        • Antibiotic Resistant Strain
          • Paris, Ile-de-France, France
            Groupe Hospitalier Paris Saint Joseph
          Mar 30, 2022

          Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)

          Not yet recruiting
          • Bronchiectasis
          • +3 more
          • (no location specified)
          Sep 6, 2023

          Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis Trial in Israel, United States (BX004-A, Placebo)

          Recruiting
          • Chronic Pseudomonas Aeruginosa Infection
          • Cystic Fibrosis
          • Hollywood, Florida
          • +7 more
          Jun 28, 2022

          Affecting Progression of Bronchiectasis

          Recruiting
          • Bronchiectasis
          • Pseudomonas aeruginosa colonization infection
          • Macrolides
          • Wuhan, Hubei, China
            Wuhan Union Hospital
          Feb 7, 2023

          Pseudomonas Aeruginosa, Pneumonia, Hematologic Malignancy Trial in New York (Ceftolozane / Tazobactam Injection)

          Suspended
          • Pseudomonas Aeruginosa
          • +2 more
          • Ceftolozane / Tazobactam Injection
          • New York, New York
            Weill Cornell Medicine
          Jan 25, 2022

          Cystic Fibrosis Trial in France (collection of expectoration, stools and blood)

          Recruiting
          • Cystic Fibrosis
          • collection of expectoration, stools and blood
          • Angers, France
          • +10 more
          Jul 12, 2022

          Trikafta/Kaftrio and Pseudomonas Aeruginosa

          Recruiting
          • Cystic Fibrosis
            • Milan, Italy
            • +1 more
            Jan 9, 2023

            Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas Trial in United States (AP-PA02, Placebo)

            Active, not recruiting
            • Cystic Fibrosis
            • +4 more
            • AP-PA02
            • Placebo
            • Los Angeles, California
            • +19 more
            Dec 20, 2022

            Resistance in Carbapenemase-producing Enterobacterales and

            Enrolling by invitation
            • Bacterial Infections
            • Antibiotic Resistant Infection
            • No intervention
            • Rio De Janeiro, Brazil
              D'Or Institute for Research and Education (IDOR)
            Mar 16, 2022

            Patients With Infection by Resistant Microorganism

            Enrolling by invitation
            • Pneumonia
            • +10 more
            • Pathogen resistant phenotype
            • Sevilla, Spain
              Hospital Universitario Virgen Macarena
            May 18, 2023

            Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa Trial in Australia, United States

            Not yet recruiting
            • Cystic Fibrosis Lung
            • +2 more
            • Tucson, Arizona
            • +14 more
            Aug 24, 2023

            Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)

            Not yet recruiting
            • Multidrug Resistant Bacterial Infection
            • +4 more
            • Philadelphia, Pennsylvania
              Hospital of the University of Pennsylvania
            Nov 17, 2022

            Bacterial Disease Carrier, Cystic Fibrosis Trial in United States (Placebo, WRAIR_PAM-CF1)

            Recruiting
            • Bacterial Disease Carrier
            • Cystic Fibrosis
            • Placebo
            • WRAIR_PAM-CF1
            • La Jolla, California
            • +14 more
            Aug 11, 2022

            Bronchiectasis Adult, Pseudomonas Aeruginosa Infection Trial in China (Tobramycin Inhalant Product, Ciprofloxacin 750 MG, Oral

            Recruiting
            • Bronchiectasis Adult
            • Pseudomonas Aeruginosa Infection
            • Tobramycin Inhalant Product
            • +3 more
            • Shanghai, Shanghai, China
            • +59 more
            Oct 16, 2023

            Ventilator-Associated Pneumonia Trial in Paris (8 days of effective antibiotic treatment, 15 days of effective antibiotic

            Completed
            • Ventilator-Associated Pneumonia
            • 8 days of effective antibiotic treatment
            • 15 days of effective antibiotic treatment
            • Paris, France
              Anesthesiology and Critical Care Medicine Institut de Cardiologi
            Oct 15, 2021

            Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection Trial in Jerusalem, Tel Aviv (TP-102)

            Recruiting
            • Diabetic Foot Ulcer
            • +3 more
            • TP-102
            • Jerusalem, Israel
            • +1 more
            Jun 17, 2022